Package 68462-129-05

{"route": ["ORAL"], "spl_id": "c00ccc2d-52c6-4a11-a310-d8db25ca3928", "openfda": {"nui": ["N0000175753", "N0000008486", "M0020790", "N0000000235", "N0000185503"], "upc": ["0368462130018", "0368462129012", "0368462128015"], "unii": ["459384H98V"], "rxcui": ["314285", "403966", "403967"], "spl_set_id": ["fe15e56e-8b86-4a65-825c-31d37dd81612"], "pharm_class_cs": ["Sulfonamides [CS]"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "pharm_class_moa": ["Carbonic Anhydrase Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (68462-129-01)", "package_ndc": "68462-129-01", "marketing_start_date": "20060130"}, {"sample": false, "description": "500 CAPSULE in 1 BOTTLE (68462-129-05)", "package_ndc": "68462-129-05", "marketing_start_date": "20060130"}], "brand_name": "Zonisamide", "product_id": "68462-129_c00ccc2d-52c6-4a11-a310-d8db25ca3928", "dosage_form": "CAPSULE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Carbonic Anhydrase Inhibitors [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "P-Glycoprotein Inhibitors [MoA]", "Sulfonamides [CS]"], "product_ndc": "68462-129", "generic_name": "Zonisamide", "labeler_name": "Glenmark Pharmaceuticals Inc., USA", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Zonisamide", "active_ingredients": [{"name": "ZONISAMIDE", "strength": "50 mg/1"}], "application_number": "ANDA077651", "marketing_category": "ANDA", "marketing_start_date": "20060130", "listing_expiration_date": "20261231"}